Literature DB >> 32830219

Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia.

Lubin Chen1,2,3, Jianying Huang1,2,3, Curtis Benson1,2,3, Karen L Lankford1,2,3, Peng Zhao1,2,3, Jennifer Carrara1,2,3, Andrew M Tan1,2,3, Jeffery D Kocsis1,2,3, Stephen G Waxman1,2,3, Sulayman D Dib-Hajj1,2,3.   

Abstract

Vincristine, a widely used chemotherapeutic agent, produces painful peripheral neuropathy. The underlying mechanisms are not well understood. In this study, we investigated whether voltage-gated sodium channels are involved in the development of vincristine-induced neuropathy. We established a mouse model in which repeated systemic vincristine treatment results in the development of significant mechanical allodynia. Histological examinations did not reveal major structural changes at proximal sciatic nerve branches or distal toe nerve fascicles at the vincristine dose used in this study. Immunohistochemical studies and in vivo two-photon imaging confirmed that there is no significant change in density or morphology of intra-epidermal nerve terminals throughout the course of vincristine treatment. These observations suggest that nerve degeneration is not a prerequisite of vincristine-induced mechanical allodynia in this model. We also provided the first detailed characterization of tetrodotoxin-sensitive (TTX-S) and resistant (TTX-R) sodium currents in dorsal root ganglion neurons following vincristine treatment. Accompanying the behavioural hyperalgesia phenotype, voltage-clamp recordings of small and medium dorsal root ganglion neurons from vincristine-treated animals revealed a significant upregulation of TTX-S Na+ current in medium but not small neurons. The increase in TTX-S Na+ current density is likely mediated by Nav1.6, because in the absence of Nav1.6 channels, vincristine failed to alter TTX-S Na+ current density in medium dorsal root ganglion neurons and, importantly, mechanical allodynia was significantly attenuated in conditional Nav1.6 knockout mice. Our data show that TTX-S sodium channel Nav1.6 is involved in the functional changes of dorsal root ganglion neurons following vincristine treatment and it contributes to the maintenance of vincristine-induced mechanical allodynia.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 in vivo two-photon imaging; CIPN; TTX-S Na+ current; intra-epidermal nerve fibre; pain

Year:  2020        PMID: 32830219     DOI: 10.1093/brain/awaa208

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

Review 1.  iPSCs and DRGs: stepping stones to new pain therapies.

Authors:  Matthew Alsaloum; Stephen G Waxman
Journal:  Trends Mol Med       Date:  2021-12-18       Impact factor: 11.951

2.  Neuroinflammation in the anterior cingulate cortex: the potential supraspinal mechanism underlying the mirror-image pain following motor fiber injury.

Authors:  Qiao-Yun Li; Shao-Xia Chen; Jin-Yu Liu; Pei-Wen Yao; Yi-Wen Duan; Yong-Yong Li; Ying Zang
Journal:  J Neuroinflammation       Date:  2022-06-20       Impact factor: 9.587

3.  Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.

Authors:  Andreas C Themistocleous; Alexander G Kristensen; Roma Sola; Sandra S Gylfadottir; Kristine Bennedsgaard; Mustapha Itani; Thomas Krøigård; Lise Ventzel; Søren H Sindrup; Troels S Jensen; Hugh Bostock; Jordi Serra; Nanna B Finnerup; Hatice Tankisi; David L H Bennett
Journal:  Ann Neurol       Date:  2022-03-07       Impact factor: 11.274

4.  Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma.

Authors:  Shuo Cheng; Hong-Ning Wang; Lin-Jie Xu; Fang Li; Yanying Miao; Bo Lei; Xinghuai Sun; Zhongfeng Wang
Journal:  J Neuroinflammation       Date:  2021-08-21       Impact factor: 8.322

Review 5.  Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders.

Authors:  Jeremy Chung Bo Chiang; Ria Arnold; Roshan Dhanapalaratnam; Maria Markoulli; Arun V Krishnan
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-15

6.  Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.

Authors:  Hana Starobova; Mercedes Monteleone; Christelle Adolphe; Lena Batoon; Cheyenne J Sandrock; Bryan Tay; Jennifer R Deuis; Alexandra V Smith; Alexander Mueller; Evelyn Israel Nadar; Grace Pamo Lawrence; Amanda Mayor; Elissa Tolson; Jean-Pierre Levesque; Allison R Pettit; Brandon J Wainwright; Kate Schroder; Irina Vetter
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

7.  Mechanisms Underlying Gastrodin Alleviating Vincristine-Induced Peripheral Neuropathic Pain.

Authors:  Xiangyu Wang; Boxuan Zhang; Xuedong Li; Xingang Liu; Songsong Wang; Yuan Xie; Jialing Pi; Zhiyuan Yang; Jincan Li; Qingzhong Jia; Yang Zhang
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

Review 8.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

9.  Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial.

Authors:  Samuel A Goldlust; Mojgan Kavoosi; Jennifer Nezzer; Mehran Kavoosi; Walter Korz; Kenneth Deck
Journal:  Toxins (Basel)       Date:  2021-03-25       Impact factor: 4.546

Review 10.  Neuropathic pain in children: Steps towards improved recognition and management.

Authors:  Suellen M Walker
Journal:  EBioMedicine       Date:  2020-11-25       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.